General Information of Drug (ID: DMT584A)

Drug Name
ALN-VEG01 Drug Info
Synonyms
RNAi therapeutics (ocular disease), Alnylam; VEGF-silencing siRNAs, Alnylam; Vascular endothelial growth factor gene-silencing siRNAs, Alnylam; RNAi therapeutics (ocular disease), Alnylam/Merck; VEGF-silencing siRNAs, Alnylam/Merck; Vascular endothelial growth factor-silencing siRNAs, Alnylam/Merck
Indication
Disease Entry ICD 11 Status REF
Macular degeneration 9B78.3 Terminated [1]
Cross-matching ID
TTD Drug ID
DMT584A

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
VEGF messenger RNA (VEGF mRNA) TT3LJ9K VEGFA_HUMAN Not Available [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025250)
2 Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals.